CRVS Corvus Pharmaceuticals, Inc. - Common Stock
$15.53
价格 · 八月 19, 2026
截至...的财报数据 八月 6, 2026
52周区间
$5–$27
48% of range
分析师评级
BUY
14 analysts
目标价
$33
+113% upside
P/E (TTM)
-29.3
ROE
-21.6%
净利润率
—
CRVS 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$15.53
市值
$1.16B
P/E (TTM)
-29.3
每股收益 (TTM)
$-0.53
营收 (TTM)
—
股息收益率
—
ROE
-21.6%
负债/权益
—
52周区间
$5 – $27
CRVS 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
—
EPS
$-0.53
2019-12-31
→
2025-12-31
自由现金流
$-33M
2018-12-31
→
2025-12-31
利润率
—
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
CRVS
同行中位数
P/E (TTM)
-29.3
—
P/B (市净率)
19.0
5.2
Price / FCF (股价/自由现金流)
-35.2
—
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
CRVS
同行中位数
ROA
-21.8%
-44.7%
ROE
-21.6%
-51.5%
ROIC
-70.2%
—
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
CRVS
同行中位数
Current Ratio (流动比率)
6.2
9.5
Quick Ratio (速动比率)
0.5
—
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
CRVS
同行中位数
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
CRVS
同行中位数
CRVS 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
14 位分析师
- 强烈买入 5 35.7%
- 买入 8 57.1%
- 持有 1 7.1%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
7 位分析师 · 2026-08-16
中位数
$32.00
← 低于所有目标
$15.53
最低
$27.00
最高
$42.00
中位数目标
$32.00
+106.1%
平均目标
$33.14
+113.4%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
0.06%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年6月30日 | $-0.19 | $-0.16 | -0.03% |
| 2026年3月31日 | $-0.15 | $-0.15 | -0.00% |
| 2025年12月31日 | $-0.15 | $-0.13 | -0.02% |
| 2025年9月30日 | $-0.12 | $-0.14 | 0.02% |
| 2025年6月30日 | $-0.10 | $-0.14 | 0.04% |
| 2025年3月31日 | $0.21 | $-0.12 | 0.33% |
同行比较（GICS 子行业） 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| CRVS | $575M | -14.5 | — | — | -21.6% | — |
| NVAX | $1.09B | 2.6 | 64.7% | 39.2% | -977.1% | — |
| CGEM | $624M | -3.2 | — | — | -44.0% | — |
| MNKD | $1.75B | 283.5 | 22.2% | 1.7% | -11.1% | — |
| AKTS | — | — | — | — | — | — |
| GLUE | $1.03B | — | 63.5% | -31.2% | -15.4% | — |
| SANA | $1.09B | -4.2 | — | — | -172.3% | — |
| VOR | $506M | -0.2 | — | — | 83.4% | — |
| ODTX | — | — | — | — | — | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 12
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $34M | $19M | $17M | $24M | $29M | $32M | $38M | $39M | $46M | $29M | $11M | |
| SG&A Expense | $9M | $8M | $7M | $8M | $10M | $12M | $11M | $11M | $10M | $8M | $2M | |
| Operating Expenses | $43M | $28M | $23M | $33M | $39M | $44M | $49M | $49M | $57M | $37M | $14M | |
| Operating Income | $-43M | $-28M | $-23M | $-33M | $-39M | $-44M | $-49M | $-49M | $-57M | $-37M | $-14M | |
| Pretax Income | $-13M | $-59M | $-22M | $-31M | $-43M | $-6M | $-47M | $-47M | $-56M | $-36M | $-31M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-15M | $-62M | $-27M | $-41M | $-43M | $-6M | $-47M | $-47M | $-56M | $-36M | $-31M | |
| EPS (Basic) | $-0.19 | $-1.02 | $-0.56 | $-0.89 | $-1.03 | $-0.20 | $-1.59 | · | · | · | · | |
| EPS (Diluted) | $-0.53 | $-1.02 | $-0.56 | $-0.89 | $-1.03 | $-0.20 | $-1.59 | · | · | · | · | |
| Shares (Basic) | 78,964,842 | 60,985,165 | 48,025,274 | 46,553,511 | 41,854,110 | 29,478,878 | 29,349,810 | · | · | · | · | |
| Shares (Diluted) | 79,742,685 | 60,985,165 | 48,025,274 | 46,553,511 | 41,854,110 | 29,478,878 | 29,349,810 | · | · | · | · | |
| EBITDA | $-43M | $-27M | $-23M | $-32M | $-38M | $-43M | $-48M | $-48M | · | · | · |
资产负债表 23
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5M | $9M | $13M | $13M | $63M | $16M | $5M | $39M | $45M | $5M | $4M | |
| Receivables | $37.0K | $75.0K | $26.0K | $588.0K | · | · | · | · | · | · | · | |
| Prepaid Expense | $1M | $2M | $781.0K | $773.0K | $1M | $1M | $1M | $992.0K | $1M | $1M | $1M | |
| Other Current Assets | $353.0K | $548.0K | $220.0K | $102.0K | $128.0K | $406.0K | $486.0K | $265.0K | $412.0K | $772.0K | $208.0K | |
| Current Assets | $58M | $54M | $28M | $44M | $71M | $45M | $79M | $116M | $91M | $136M | $96M | |
| PP&E (Net) | $220.0K | $151.0K | $236.0K | $353.0K | $451.0K | $906.0K | $1M | $2M | $3M | $3M | $2M | |
| PP&E (Gross) | $3M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | $2M | |
| Accum. Depreciation | $3M | $5M | $5M | $5M | $4M | $4M | $3M | $2M | $2M | $729.0K | $135.0K | |
| Other Non-current Assets | $855.0K | $632.0K | $89.0K | $129.0K | $236.0K | $414.0K | $513.0K | $463.0K | $869.0K | $869.0K | · | |
| Total Assets | $71M | $69M | $46M | $68M | $109M | $86M | $84M | $118M | $95M | $140M | $98M | |
| Accounts Payable | $2M | $3M | $2M | $2M | $2M | $3M | $2M | $2M | $3M | $2M | $2M | |
| Accrued Liabilities | $6M | $4M | $4M | · | · | · | · | · | · | · | · | |
| Current Liabilities | $9M | $35M | $7M | $11M | $10M | $12M | $10M | $7M | $9M | $6M | $3M | |
| Capital Leases | $534.0K | $937.0K | · | $1M | $3M | $1M | $2M | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | $869.0K | $971.0K | $1M | $710.0K | |
| Total Liabilities | $10M | $36M | $7M | $12M | $12M | $13M | $13M | $8M | $10M | $7M | $4M | |
| Common Stock | $7.0K | $7.0K | $5.0K | $5.0K | $5.0K | $3.0K | $3.0K | $3.0K | $2.0K | $2.0K | · | |
| Paid-in Capital | $474M | $431M | · | · | · | · | · | · | · | · | · | |
| Retained Earnings | $-412M | $-397M | $-335M | $-308M | $-266M | $-223M | $-217M | $-170M | $-124M | $-68M | $-31M | |
| AOCI | $-896.0K | $-1M | $-967.0K | $-563.0K | $2M | $4.0K | $29.0K | $-34.0K | $-41.0K | $-39.0K | $-45.0K | |
| Stockholders' Equity | $61M | $33M | $39M | $56M | $97M | $72M | $71M | $110M | $85M | $133M | $-31M | |
| Liabilities + Equity | $71M | $69M | $46M | $68M | $109M | $86M | $84M | $118M | $95M | $140M | $98M | |
| Shares Outstanding | 74,696,629 | 67,899,779 | 49,038,582 | 46,553,511 | 46,553,511 | 28,372,634 | 27,953,233 | 29,323,930 | 21,041,250 | 20,922,428 | 1,431,615 |
现金流 12
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $105.0K | $85.0K | $151.0K | $367.0K | $460.0K | $632.0K | $743.0K | $847.0K | $842.0K | $594.0K | $148.0K | |
| Stock-based Comp | $5M | $3M | $2M | $3M | $4M | $6M | $7M | $7M | $6M | $4M | $428.0K | |
| Other Non-cash | $-23M | $34M | $796.0K | $11M | $2M | $-35M | $1M | $-2M | · | · | · | |
| Operating Cash Flow | $-33M | $-25M | $-24M | $-27M | $-37M | $-35M | $-37M | $-41M | $-46M | $-28M | $-11M | |
| CapEx | $174.0K | · | $34.0K | $269.0K | $5.0K | $76.0K | $25.0K | $355.0K | $266.0K | $2M | $2M | |
| Investing Cash Flow | $-8M | $-27M | $16M | $-23M | $22M | $45M | $3M | $-30M | $85M | $-43M | $-92M | |
| Stock Issued | · | $16M | · | · | $32M | · | · | $65M | $711.0K | $71M | · | |
| Net Stock Activity | · | $16M | · | · | $32M | · | · | $65M | · | · | · | |
| Financing Cash Flow | $36M | $49M | $8M | $0 | $62M | $1M | $24.0K | $65M | $1M | $71M | $95M | |
| Net Change in Cash | $-4M | $-4M | $-539.0K | $-50M | $47M | $11M | $-34M | $-6M | $40M | $945.0K | $-8M | |
| Taxes Paid | $0 | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-33M | · | $-24M | $-27M | $-37M | $-35M | $-37M | $-41M | · | · | · |
盈利能力 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -21.8% | -108.9% | -47.5% | -46.5% | -44.4% | -7.1% | -46.2% | -44.1% | · | · | · | |
| ROE | -21.6% | -277.0% | -65.1% | -68.4% | -42.8% | -10.5% | -61.6% | -41.0% | · | · | · | |
| ROIC | -70.2% | -84.6% | -60.5% | -58.0% | -39.8% | -60.7% | -68.7% | -44.6% | · | · | · |
流动性与偿付能力 2
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.2 | 1.5 | 4.1 | 4.1 | 7.4 | 3.7 | 7.8 | 16.4 | · | · | · | |
| Quick Ratio | 0.5 | 0.2 | 1.8 | 1.2 | 6.5 | 1.4 | 0.5 | 5.6 | · | · | · |
估值 (TTM) 8
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-15M | $-62M | $-27M | $-41M | $-43M | $-6M | $-47M | $-47M | $-56M | $-36M | · | |
| Market Cap | $575M | $363M | $86M | $40M | $112M | $101M | $152M | $108M | · | · | · | |
| P/E | -14.5 | -5.2 | -3.1 | -1.0 | -2.3 | -17.8 | -3.4 | · | · | · | · | |
| P/B | 9.4 | 11.2 | 2.2 | 0.7 | 1.2 | 1.4 | 2.1 | 1.0 | · | · | · | |
| P / Tangible Book | 9.4 | 11.2 | 2.2 | 0.7 | 1.2 | 1.4 | · | · | · | · | · | |
| P / Cash Flow | -17.5 | -14.3 | -3.6 | -1.5 | -3.1 | -2.9 | -4.1 | -2.6 | · | · | · | |
| P / FCF | -17.4 | · | -3.6 | -1.4 | -3.1 | -2.9 | -4.1 | -2.6 | · | · | · | |
| Earnings Yield | -6.9% | -19.1% | -31.8% | -104.7% | -42.7% | -5.6% | -29.2% | · | · | · | · |
损益表 13
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $16M | $11M | $10M | $8M | $8M | $7M | $6M | $5M | $4M | $4M | $4M | $4M | $4M | $5M | $10M | $5M | |
| SG&A Expense | $3M | $4M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Operating Expenses | $19M | $15M | $12M | $11M | $10M | $10M | $8M | $7M | $6M | $6M | $6M | $6M | $6M | $7M | $12M | $7M | |
| Operating Income | $-19M | $-15M | $-12M | $-11M | $-10M | $-10M | $-8M | $-7M | $-6M | $-6M | $-6M | $-6M | $-6M | $-7M | $-12M | $-7M | |
| Other Non-op | · | $1M | · | $415.0K | $2M | $25M | · | $-33M | $2M | $-552.0K | · | · | · | · | · | · | |
| Pretax Income | $-17M | $-13M | $-12M | $-10M | $-8M | $16M | $-10M | $-40M | $-4M | $-6M | $-5M | $-5M | $-5M | $-6M | · | · | |
| Income Tax | $0 | $0 | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-18M | $-14M | $-12M | $-10M | $-8M | $15M | $-12M | $-40M | $-4M | $-6M | $-7M | $-6M | $-7M | $-8M | $-15M | $-8M | |
| EPS (Basic) | $-0.19 | $-0.15 | $-0.18 | $-0.12 | $-0.10 | $0.21 | $-0.23 | $-0.60 | $-0.07 | $-0.12 | $-0.13 | $-0.12 | $-0.14 | $-0.17 | $-0.32 | $-0.18 | |
| EPS (Diluted) | $-0.19 | $-0.15 | $-0.18 | $-0.12 | $-0.10 | $-0.13 | $-0.23 | $-0.60 | $-0.07 | $-0.12 | $-0.13 | $-0.12 | $-0.14 | $-0.17 | $-0.32 | $-0.18 | |
| Shares (Basic) | 92,368,013 | 89,996,728 | -153,772,367 | 82,836,369 | 77,774,344 | 72,126,496 | -114,464,768 | 66,701,086 | 59,710,265 | 49,038,582 | -94,999,564 | 48,971,246 | 47,497,414 | 46,556,178 | 46,553,511 | 46,553,511 | |
| Shares (Diluted) | 92,368,013 | 89,996,728 | -156,020,542 | 82,836,369 | 77,774,344 | 75,152,514 | -114,464,768 | 66,701,086 | 59,710,265 | 49,038,582 | -94,999,564 | 48,971,246 | 47,497,414 | 46,556,178 | 46,553,511 | 46,553,511 | |
| EBITDA | $-19M | $-15M | · | $-11M | $-10M | $-10M | · | $-7M | $-6M | $-6M | · | $-6M | $-6M | $-7M | $-12M | $-7M |
资产负债表 22
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $19M | $40M | $5M | $3M | $15M | $5M | $9M | $5M | $15M | $7M | · | $20M | $8M | $10M | $25M | $28M | |
| Receivables | $6.0K | $43.0K | $37.0K | $32.0K | $86.0K | $79.0K | $75.0K | $70.0K | $35.0K | $26.0K | · | $11.0K | · | · | · | · | |
| Prepaid Expense | $6M | $3M | $1M | $1M | $1M | $1M | $2M | $1M | $977.0K | $697.0K | · | $915.0K | $893.0K | $655.0K | $1M | $2M | |
| Other Current Assets | $575.0K | $367.0K | $318.0K | $509.0K | $569.0K | $458.0K | $548.0K | $633.0K | $240.0K | $267.0K | · | $214.0K | $136.0K | $131.0K | $397.0K | $395.0K | |
| Current Assets | $221M | $240M | $58M | $67M | $76M | $45M | $54M | $43M | $48M | $23M | · | $33M | $38M | $36M | $51M | $59M | |
| PP&E (Net) | $830.0K | $282.0K | $220.0K | $221.0K | $249.0K | $165.0K | $151.0K | $171.0K | $192.0K | $213.0K | · | $264.0K | $294.0K | $330.0K | $447.0K | $527.0K | |
| PP&E (Gross) | $4M | $3M | $3M | $3M | $3M | $3M | $5M | $5M | $5M | $5M | · | $5M | $5M | $5M | $5M | $5M | |
| Accum. Depreciation | $3M | $3M | $3M | $3M | $3M | $3M | $5M | $5M | $5M | $5M | · | $5M | $5M | $5M | $5M | $4M | |
| Other Non-current Assets | $2M | $2M | $855.0K | $852.0K | $626.0K | $629.0K | $632.0K | $252.0K | $129.0K | $89.0K | · | $89.0K | $129.0K | $129.0K | $248.0K | $236.0K | |
| Total Assets | $239M | $253M | $71M | $80M | $89M | $59M | $69M | $59M | $65M | $40M | · | $52M | $58M | $58M | $80M | $93M | |
| Accounts Payable | $4M | $5M | $2M | $2M | $3M | $1M | $3M | $2M | $1M | $2M | · | $1M | $2M | $1M | $4M | $3M | |
| Accrued Liabilities | $9M | $7M | $6M | $6M | $5M | $4M | $4M | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $14M | $12M | $9M | $8M | $9M | $9M | $35M | $46M | $13M | $7M | · | $7M | $8M | $8M | $14M | $10M | |
| Capital Leases | $274.0K | $406.0K | $534.0K | $632.0K | $728.0K | $834.0K | $937.0K | · | · | · | · | $354.0K | $700.0K | $1M | $2M | $2M | |
| Total Liabilities | $14M | $13M | $10M | $9M | $9M | $10M | $36M | $46M | $13M | $7M | · | $8M | $9M | $9M | $16M | $12M | |
| Common Stock | $8.0K | $8.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $6.0K | $6.0K | $5.0K | · | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | |
| Paid-in Capital | $671M | $668M | $474M | · | · | · | $431M | · | · | · | · | · | · | · | · | · | |
| Retained Earnings | $-444M | $-426M | $-412M | $-400M | $-390M | $-382M | $-397M | $-385M | $-345M | $-340M | · | $-328M | $-322M | $-316M | $-298M | $-283M | |
| AOCI | $-1M | $-1M | $-896.0K | $-1M | $-1M | $-1M | $-1M | $-738.0K | $-1M | $-1M | · | $-1M | $-1M | $-434.0K | $-1M | $339.0K | |
| Stockholders' Equity | $225M | $241M | $61M | $72M | $80M | $49M | $33M | $12M | $51M | $33M | $39M | $44M | $49M | $49M | $65M | $80M | |
| Liabilities + Equity | $239M | $253M | $71M | $80M | $89M | $59M | $69M | $59M | $65M | $40M | · | $52M | $58M | $58M | $80M | $93M | |
| Shares Outstanding | 84,120,944 | 84,090,424 | 74,696,629 | 74,681,872 | 74,514,039 | 68,169,461 | 67,899,779 | 62,580,031 | 62,551,281 | 49,038,582 | · | 49,038,582 | 48,898,362 | 46,568,511 | 46,553,511 | 46,553,511 |
现金流 11
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $34.0K | $29.0K | $26.0K | $28.0K | $29.0K | $22.0K | $20.0K | $21.0K | $21.0K | $23.0K | $28.0K | $30.0K | $36.0K | $57.0K | $94.0K | $92.0K | |
| Stock-based Comp | $3M | $3M | $2M | $1M | $1M | $1M | $813.0K | $733.0K | $768.0K | $689.0K | $572.0K | $546.0K | $537.0K | $492.0K | $658.0K | $675.0K | |
| Other Non-cash | · | $639.0K | · | · | · | $-25M | · | · | · | $-168.0K | · | · | · | $-787.0K | · | · | |
| Operating Cash Flow | $-15M | $-10M | $-9M | $-10M | $-6M | $-8M | $-8M | $-6M | $-5M | $-5M | $-5M | $-5M | $-5M | $-8M | $-7M | $-6M | |
| CapEx | $582.0K | $91.0K | $25.0K | $0 | $113.0K | $36.0K | · | · | · | · | $0 | $0 | $0 | $34.0K | $265.0K | · | |
| Investing Cash Flow | $-6M | $-145M | $11M | $-3M | $-20M | $4M | $-6M | $-4M | $-18M | $-7.0K | $-2M | $18M | $-4M | $5M | $3M | $3M | |
| Stock Issued | $0 | $189M | · | · | · | · | $0 | $0 | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $189M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $166.0K | $191M | $20.0K | $360.0K | $36M | $279.0K | $19M | $50.0K | · | · | $0 | $335.0K | $8M | $4.0K | · | · | |
| Net Change in Cash | $-21M | $36M | $2M | $-12M | $10M | $-4M | $4M | $-10M | $7M | $-5M | $-7M | $12M | $-2M | $-4M | $-4M | $-3M | |
| Free Cash Flow | · | $-10M | · | · | · | $-8M | · | · | · | · | · | · | · | $-8M | · | · |
盈利能力 3
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -10.9% | -8.8% | · | -14.6% | -10.4% | 30.5% | · | -72.6% | -7.0% | -11.6% | · | -9.1% | -8.6% | -9.9% | -14.9% | -8.3% | |
| ROE | -11.8% | -9.4% | · | -24.1% | -12.2% | 36.8% | · | -141.9% | -8.5% | -13.9% | · | -11.0% | -10.0% | -11.4% | -17.5% | -9.5% | |
| ROIC | · | -6.2% | · | · | · | · | · | · | · | -18.7% | · | · | · | · | · | · |
流动性与偿付能力 2
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 16.2 | 19.8 | · | 8.3 | 8.9 | 4.9 | · | 0.9 | 3.6 | 3.4 | · | 4.5 | 4.8 | 4.3 | 3.7 | 5.8 | |
| Quick Ratio | 1.4 | 3.3 | · | 0.4 | 1.7 | 0.5 | · | 0.1 | 1.1 | 1.1 | · | 2.8 | 1.0 | 1.2 | 1.8 | 2.8 |
估值 (TTM) 8
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-50M | $-17M | · | $-43M | $-37M | $-35M | · | $-56M | $-22M | $-26M | · | $-35M | $-38M | $-39M | $-42M | $-39M | |
| Market Cap | $1.26B | $1.23B | · | $550M | $298M | $217M | · | $330M | $114M | $87M | · | $72M | $112M | $42M | $38M | $46M | |
| P/E | -26.7 | -29.3 | · | -7.8 | -4.4 | -3.5 | · | -5.8 | -4.0 | -3.2 | · | -1.9 | -2.8 | -1.1 | -0.9 | -1.2 | |
| P/B | 5.6 | 5.1 | · | 7.7 | 3.7 | 4.4 | · | 26.6 | 2.2 | 2.6 | · | 1.6 | 2.3 | 0.9 | 0.6 | 0.6 | |
| P / Tangible Book | 5.6 | 5.1 | · | 7.7 | 3.7 | 4.4 | · | 26.6 | 2.2 | 2.6 | · | 1.6 | 2.3 | 0.9 | 0.6 | 0.6 | |
| P / Cash Flow | · | -118.6 | · | · | · | -26.2 | · | · | · | -16.9 | · | · | · | -5.2 | · | · | |
| P / FCF | · | -117.6 | · | · | · | -26.1 | · | · | · | · | · | · | · | -5.2 | · | · | |
| Earnings Yield | -3.8% | -3.4% | · | -12.9% | -22.5% | -28.9% | · | -17.2% | -24.7% | -30.9% | · | -51.4% | -35.4% | -93.4% | -107.5% | -80.8% |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 净收入 | $-15M | $-62M | $-27M | $-41M | $-43M |
| 稀释后每股收益 (EPS) | $-0.53 | $-1.02 | $-0.56 | $-0.89 | $-1.03 |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 流动比率 | 6.2 | 1.5 | 4.1 | 4.1 | 7.4 |
| 速动比率 | 0.5 | 0.2 | 1.8 | 1.2 | 6.5 |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 自由现金流 | $-33M | — | $-24M | $-27M | $-37M |
最新新闻 提及该公司的近期头条新闻
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。
机构持有人 (13F) 189 家申报者 · $850.4M 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 47 (-22 与上一季度对比) | 28 (+7 与上一季度对比) | 68 (+9 与上一季度对比) | 40 (+13 与上一季度对比) | +3.3M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| ORBIMED ADVISORS LLC | $107045190 | 7165006 | 12.59% | 股份 |
| STATE STREET CORP | $66842920 | 4474091 | 7.86% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $49193087 | 3292710 | 5.78% | 股份 |
| ADAMS STREET PARTNERS LLC | $48937703 | 3275616 | 5.75% | 股份 |
| Vivo Capital, LLC | $41918891 | 2805816 | 4.93% | 股份 |
| PERCEPTIVE ADVISORS LLC | $39851569 | 2667441 | 4.69% | 股份 |
| Deep Track Capital, LP | $37229569 | 2491939 | 4.38% | 股份 |
| BRAIDWELL LP | $31766892 | 2126298 | 3.74% | 股份 |
| WELLINGTON MANAGEMENT GROUP LLP | $28099301 | 1880810 | 3.30% | 股份 |
| Foresite Capital Management VI LLC | $27358621 | 1831233 | 3.22% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $23775864 | 1590939 | 2.80% | 股份 |
| Hood River Capital Management LLC | $23482767 | 1571805 | 2.76% | 股份 |
| GOLDMAN SACHS GROUP INC | $19824246 | 1326924 | 2.33% | 股份 |
| Boxer Capital Management, LLC | $16434000 | 1100000 | 1.93% | 股份 |
| Catalio Capital Management, LP | $16148467 | 1080888 | 1.90% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $15656896 | 1047985 | 1.84% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $12172365 | 814750 | 1.43% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $11731008 | 785208 | 1.38% | 股份 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $11205000 | 750000 | 1.32% | 股份 |
| Eversept Partners, LP | $11175030 | 747994 | 1.31% | 股份 |
| EMERALD ADVISERS, LLC | $10244104 | 685683 | 1.20% | 股份 |
| BANK OF AMERICA CORP /DE/ | $10073400 | 674257 | 1.18% | 股份 |
| DCF Advisers, LLC | $9524250 | 637500 | 1.12% | 股份 |
| Blue Owl Capital Holdings LP | $9092484 | 608600 | 1.07% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $8739900 | 585000 | 1.03% | 买入期权 |
| EMERALD MUTUAL FUND ADVISERS TRUST | $7864252 | 526389 | 0.92% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $7776688 | 520528 | 0.91% | 股份 |
| RA CAPITAL MANAGEMENT, L.P. | $6723000 | 450000 | 0.79% | 股份 |
| Nextech Invest Ltd. | $6723000 | 450000 | 0.79% | 股份 |
| CITADEL ADVISORS LLC | $6675192 | 446800 | 0.78% | 买入期权 |
| CITADEL ADVISORS LLC | $5945388 | 397951 | 0.70% | 股份 |
| Jump Financial, LLC | $4682196 | 313400 | 0.55% | 股份 |
| BARCLAYS PLC | $4589313 | 307183 | 0.54% | 股份 |
| Trexquant Investment LP | $4427424 | 296347 | 0.52% | 股份 |
| DIADEMA PARTNERS LP | $4404476 | 294811 | 0.52% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $4101030 | 274500 | 0.48% | 卖出期权 |
| Polymer Capital Management (HK) LTD | $3939110 | 263662 | 0.46% | 股份 |
| Brevan Howard Capital Management LP | $3739348 | 250291 | 0.44% | 股份 |
| SPHERA FUNDS MANAGEMENT LTD. | $3659717 | 244961 | 0.43% | 股份 |
| Spruce Street Capital LP | $3459880 | 231585 | 0.41% | 股份 |
| SEB Asset Management AB | $3388938 | 226837 | 0.40% | 股份 |
| VICTORY CAPITAL MANAGEMENT INC | $3298169 | 220761 | 0.39% | 股份 |
| Connor, Clark & Lunn Investment Management Ltd. | $3253185 | 217750 | 0.38% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $3109298 | 208119 | 0.37% | 股份 |
| CITADEL ADVISORS LLC | $2959614 | 198100 | 0.35% | 卖出期权 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2848177 | 190641 | 0.33% | 股份 |
| Caption Management, LLC | $2838600 | 190000 | 0.33% | 买入期权 |
| F/m Investments LLC | $2497445 | 167165 | 0.29% | 股份 |
| JANE STREET GROUP, LLC | $2094588 | 140200 | 0.25% | 买入期权 |
| BlackRock, Inc. | $2085251 | 139575 | 0.25% | 股份 |
| DIADEMA PARTNERS LP | $1992996 | 133400 | 0.23% | 买入期权 |
| Swiss National Bank | $1889910 | 126500 | 0.22% | 股份 |
| Aquatic Capital Management LLC | $1762920 | 118000 | 0.21% | 股份 |
| ADAR1 Capital Management, LLC | $1749489 | 117101 | 0.21% | 股份 |
| CITIGROUP INC | $1664555 | 111416 | 0.20% | 股份 |
| Caption Management, LLC | $1664316 | 111400 | 0.20% | 卖出期权 |
| MARSHALL WACE, LLP | $1501082 | 100474 | 0.18% | 股份 |
| SIMPLEX TRADING, LLC | $1379604 | 92343 | 0.16% | 股份 |
| ALLIANCEBERNSTEIN L.P. | $1322845 | 90420 | 0.16% | 股份 |
| RHUMBLINE ADVISERS | $1285128 | 86020 | 0.15% | 股份 |
| ALPS ADVISORS INC | $1274980 | 85340 | 0.15% | 股份 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $1238631 | 82907 | 0.15% | 股份 |
| Seven Fleet Capital Management LP | $1238377 | 82890 | 0.15% | 股份 |
| TD Asset Management Inc | $1233984 | 82596 | 0.15% | 股份 |
| Rafferty Asset Management, LLC | $1217520 | 81494 | 0.14% | 股份 |
| SEI INVESTMENTS CO | $1195290 | 80006 | 0.14% | 股份 |
| Avidity Partners Management LP | $1195200 | 80000 | 0.14% | 股份 |
| Persistent Asset Partners Ltd | $1117452 | 74796 | 0.13% | 股份 |
| Bank of New York Mellon Corp | $1094011 | 73227 | 0.13% | 股份 |
| Propel Bio Management, LLC | $1051477 | 70380 | 0.12% | 股份 |
| TOWERVIEW LLC | $1045800 | 70000 | 0.12% | 股份 |
| D. E. Shaw & Co., Inc. | $967768 | 64777 | 0.11% | 股份 |
| Caption Management, LLC | $956668 | 64034 | 0.11% | 股份 |
| JACKSON SQUARE CAPITAL, LLC | $952769 | 63773 | 0.11% | 股份 |
| WELLS FARGO & COMPANY/MN | $920155 | 61590 | 0.11% | 股份 |
| TUDOR INVESTMENT CORP ET AL | $902376 | 60400 | 0.11% | 买入期权 |
| Ancora Advisors LLC | $847442 | 56723 | 0.10% | 股份 |
| SEVEN GRAND MANAGERS, LLC | $747000 | 50000 | 0.09% | 股份 |
| GROUP ONE TRADING LLC | $721482 | 48292 | 0.08% | 股份 |
| Vanguard Global Advisers, LLC | $712459 | 47688 | 0.08% | 股份 |
| VANGUARD ASSET MANAGEMENT, Ltd | $660632 | 44219 | 0.08% | 股份 |
| Squarepoint Ops LLC | $660423 | 44205 | 0.08% | 股份 |
| Y-Intercept (Hong Kong) Ltd | $653909 | 43769 | 0.08% | 股份 |
| TEMA ETFS LLC | $613675 | 79698 | 0.07% | 股份 |
| PROFUND ADVISORS LLC | $613197 | 41044 | 0.07% | 股份 |
| MetLife Investment Management, LLC | $592341 | 39648 | 0.07% | 股份 |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $559159 | 37427 | 0.07% | 股份 |
| AVITY INVESTMENT MANAGEMENT INC. | $555021 | 37150 | 0.07% | 股份 |
| Engineers Gate Manager LP | $538124 | 36019 | 0.06% | 股份 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $494365 | 33090 | 0.06% | 股份 |
| STATE OF WISCONSIN INVESTMENT BOARD | $414719 | 27759 | 0.05% | 股份 |
| Optimize Financial Inc | $410518 | 28060 | 0.05% | 股份 |
| Virtus Investment Advisers, LLC | $409759 | 27427 | 0.05% | 股份 |
| ACT CAPITAL MANAGEMENT, LLC | $403380 | 27000 | 0.05% | 股份 |
| Invesco Ltd. | $402917 | 26969 | 0.05% | 股份 |
| NEW YORK STATE COMMON RETIREMENT FUND | $374994 | 25100 | 0.04% | 股份 |
| SIMON QUICK ADVISORS, LLC | $373500 | 25000 | 0.04% | 股份 |
| PEAK6 LLC | $352584 | 23600 | 0.04% | 买入期权 |
| WINTON GROUP Ltd | $346608 | 23200 | 0.04% | 股份 |
| TUDOR INVESTMENT CORP ET AL | $328560 | 21992 | 0.04% | 股份 |
公司内部人士 19 位内幕人士 · 8 位高管 · 10 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Richard A Miller MD | President and CEO | 2023年3月31日 A | 1163507 | 0 | 0 | $0 |
| Leiv Lea | Chief Financial Officer | 2018年12月21日 P | 24700 | 0 | 0 | $0 |
| Mehrdad Mobasher | Chief Medical Officer | 2019年1月28日 A | — | 0 | 0 | $0 |
| Daniel W. Hunt | SVP, Chief Business Officer | 2018年12月12日 A | — | 0 | 0 | $0 |
| William Benton Jones | SVP, Pharmaceutical Development | 2018年12月12日 A | — | 0 | 0 | $0 |
| Erik J. Verner | V.P., Chemistry Research | 2018年12月12日 A | — | 0 | 0 | $0 |
| Joseph J Buggy | EVP Discovery Research | 2018年12月12日 A | — | 0 | 0 | $0 |
| Jason V Coloma | SVP, Chief Business Officer | 2016年6月8日 A | — | 0 | 0 | $0 |
| David Scott Moore | 董事 | 2026年6月11日 A | 21700 | 1 | 0 | $250201 |
| Richard Van Den Broek | 董事 | 2026年6月11日 A | — | 0 | 0 | $0 |
| Linda S Grais | 董事 | 2026年6月11日 A | — | 0 | 0 | $0 |
| Peter A. Thompson | 董事 | 2026年6月11日 A | 210000 | 0 | 0 | $0 |
| Ian T Clark | 董事 | 2026年6月11日 A | — | 0 | 0 | $0 |
| Steve E. Krognes | 董事 | 2019年6月20日 A | — | 0 | 0 | $0 |
| Scott W Morrison | 董事 | 2019年6月20日 A | — | 0 | 0 | $0 |
| Terry P Gould | 董事 | 2019年6月20日 A | 126806 | 0 | 0 | $0 |
| ORBIMED ADVISORS LLC | 董事 | 2016年3月29日 C | 5258450 | 0 | 0 | $0 |
| Adams Street Partners, LLC | 10% 所有者 | 2022年8月11日 A | 126806 | 0 | 0 | $0 |
| Novo Holdings A/S | 10% 所有者 | 2020年7月8日 S | 1389498 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
激进投资者及 5%+ 股东 5 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Adams Street Partners, LLC, Adams Street 2011 Direct Fund LP, Adams Street 2012 Direct Fund LP, Adams Street 2013 Direct Fund LP, Adams Street 2014 Direct Fund LP, Adams Street 2015 Direct Venture/Growth Fund LP, Adams Street 2016 Direct Venture/Growth Fund LP, Adams Street 2017 Direct Venture/Growth Fund LP, Adams Street 2018 Direct Venture/Growth Fund LP, Adams Street Venture/Growth Fund VI LP ×2 申报 | 2026年2月5日 | 3.90% | 修订 | — | SEC |
| ORBIMED ADVISORS LLC, ORBIMED CAPITAL GP V LLC ×13 申报 | 2026年1月27日 | 10.30% | 修订 | — | SEC |
| Novo Holdings A/S ×2 申报 | 2020年7月9日 | — | 初始申报 | — | SEC |
| Novo Holdings A/S (formerly known as Novo A/S) | 2019年1月31日 | — | 初始申报 | — | SEC |
| Novo A/S | 2016年3月30日 | — | 初始申报 | 被动投资 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 36 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| LFSC · RBB Fund, Inc. | 1.95% | 165305 NS | 2026年5月31日 | N-PORT |
| BBC · ETFis Series Trust I | 1.34% | 32976 NS | 2026年4月30日 | N-PORT |
| CANC · Tema ETF Trust | 0.76% | 108477 NS | 2026年5月31日 | N-PORT |
| SBIO · ALPS ETF Trust | 0.66% | 86347 NS | 2026年5月31日 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0.35% | 121201 NS | 2026年4月30日 | N-PORT |
| BIB · ProShares Trust | 0.05% | 3054 NS | 2026年5月31日 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0.04% | 29277 NS | 2026年5月31日 | N-PORT |
| RSSL · Global X Funds | 0.03% | 27905 NS | 2026年4月30日 | N-PORT |
| ITWO · ProShares Trust | 0.02% | 3029 NS | 2026年5月31日 | N-PORT |
| UWM · ProShares Trust | 0.01% | 2369 NS | 2026年5月31日 | N-PORT |
| URTY · ProShares Trust | 0.01% | 2398 NS | 2026年5月31日 | N-PORT |
| HDG · ProShares Trust | 0.00% | 60 NS | 2026年5月31日 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0.00% | 27317 NS | 2026年5月31日 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1515 NS | 2026年5月31日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 2026年7月15日 | 每日 |
| VTI · VANGUARD INDEX FUNDS | — | — | 2026年7月15日 | 每日 |
| VFMO · VANGUARD WELLINGTON FUND | — | — | 2026年7月30日 | 每日 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| ITOT · iShares Trust | — | — | 2026年8月5日 | 每日 |
| IWV · iShares Trust | — | — | 2026年8月18日 | 每日 |
| IWO · iShares Trust | — | — | 2026年8月18日 | 每日 |
| IWM · iShares Trust | — | — | 2026年8月18日 | 每日 |
| IBB · iShares Trust | — | — | 2026年8月18日 | 每日 |
| IWC · iShares Trust | — | — | 2026年8月18日 | 每日 |
| PKW · Invesco Exchange-Traded Fund Trust | — | — | 2026年8月4日 | 每日 |
| VHT · VANGUARD WORLD FUND | — | — | 2026年7月20日 | 每日 |
| ISCB · iShares Trust | — | — | 2026年8月5日 | 每日 |
| ISCG · iShares Trust | — | — | 2026年8月5日 | 每日 |
| ISCV · iShares Trust | — | — | 2026年8月5日 | 每日 |
| SMLF · iShares Trust | — | — | 2026年8月10日 | 每日 |
| IDNA · iShares Trust | — | — | 2026年8月12日 | 每日 |
| TECB · iShares Trust | — | — | 2026年8月5日 | 每日 |
| WSML · iShares Trust | — | — | 2026年8月5日 | 每日 |
| IBBQ · Invesco Exchange-Traded Fund Trus... | — | — | 2026年7月20日 | 每日 |